Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 32 | 2023 | 327 | 4.960 |
Why?
|
| Cognition Disorders | 16 | 2020 | 385 | 3.680 |
Why?
|
| Dementia | 20 | 2023 | 252 | 3.300 |
Why?
|
| Cognition | 23 | 2022 | 555 | 2.020 |
Why?
|
| Neuropsychological Tests | 19 | 2019 | 371 | 1.690 |
Why?
|
| Aged | 66 | 2023 | 10301 | 1.460 |
Why?
|
| Apolipoprotein E4 | 7 | 2020 | 63 | 1.430 |
Why?
|
| Apolipoproteins E | 7 | 2019 | 95 | 1.250 |
Why?
|
| Aging | 8 | 2022 | 946 | 1.220 |
Why?
|
| Residence Characteristics | 6 | 2022 | 191 | 1.140 |
Why?
|
| Humans | 87 | 2023 | 32005 | 1.110 |
Why?
|
| Female | 69 | 2023 | 19959 | 1.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2022 | 1428 | 1.080 |
Why?
|
| Aged, 80 and over | 35 | 2023 | 3990 | 1.050 |
Why?
|
| Male | 53 | 2022 | 19165 | 0.870 |
Why?
|
| Cholesterol | 3 | 2019 | 252 | 0.870 |
Why?
|
| Diet | 5 | 2023 | 391 | 0.860 |
Why?
|
| Women's Health | 8 | 2023 | 235 | 0.820 |
Why?
|
| Risk Factors | 24 | 2023 | 3876 | 0.810 |
Why?
|
| Cardiovascular Diseases | 8 | 2022 | 1128 | 0.790 |
Why?
|
| Atherosclerosis | 3 | 2022 | 766 | 0.770 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2022 | 835 | 0.740 |
Why?
|
| Sleep | 2 | 2018 | 92 | 0.740 |
Why?
|
| Brain | 8 | 2021 | 951 | 0.700 |
Why?
|
| Inflammation | 3 | 2019 | 530 | 0.690 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2020 | 53 | 0.670 |
Why?
|
| Resilience, Psychological | 1 | 2019 | 18 | 0.670 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 81 | 0.640 |
Why?
|
| Delirium | 1 | 2018 | 13 | 0.630 |
Why?
|
| Environment | 1 | 2018 | 54 | 0.620 |
Why?
|
| Social Environment | 1 | 2018 | 79 | 0.610 |
Why?
|
| Lipids | 1 | 2019 | 232 | 0.590 |
Why?
|
| Membrane Transport Proteins | 2 | 2019 | 35 | 0.580 |
Why?
|
| Longevity | 3 | 2014 | 24 | 0.540 |
Why?
|
| Utah | 11 | 2012 | 15 | 0.510 |
Why?
|
| Middle Aged | 24 | 2022 | 11817 | 0.490 |
Why?
|
| Cross-Cultural Comparison | 1 | 2014 | 26 | 0.480 |
Why?
|
| Incidence | 11 | 2022 | 1199 | 0.470 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 39 | 0.450 |
Why?
|
| Dementia, Vascular | 5 | 2020 | 12 | 0.450 |
Why?
|
| Proportional Hazards Models | 9 | 2018 | 753 | 0.440 |
Why?
|
| Vitamin E | 3 | 2008 | 23 | 0.440 |
Why?
|
| Longitudinal Studies | 11 | 2018 | 767 | 0.420 |
Why?
|
| Postmenopause | 4 | 2019 | 430 | 0.420 |
Why?
|
| Cohort Studies | 10 | 2022 | 1817 | 0.410 |
Why?
|
| Overweight | 5 | 2022 | 280 | 0.410 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2008 | 72 | 0.400 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 184 | 0.390 |
Why?
|
| Memory Disorders | 1 | 2012 | 54 | 0.390 |
Why?
|
| Prevalence | 8 | 2022 | 981 | 0.380 |
Why?
|
| Weight Loss | 6 | 2022 | 480 | 0.370 |
Why?
|
| Life Style | 6 | 2022 | 408 | 0.360 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2022 | 54 | 0.350 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2010 | 85 | 0.340 |
Why?
|
| Sex Characteristics | 3 | 2020 | 173 | 0.330 |
Why?
|
| Obesity | 7 | 2022 | 1175 | 0.330 |
Why?
|
| Genotype | 5 | 2012 | 733 | 0.320 |
Why?
|
| Follow-Up Studies | 11 | 2020 | 2265 | 0.310 |
Why?
|
| Risk | 5 | 2021 | 321 | 0.300 |
Why?
|
| Pesticides | 1 | 2010 | 199 | 0.300 |
Why?
|
| Occupational Exposure | 1 | 2010 | 232 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2021 | 1328 | 0.280 |
Why?
|
| Cerebrovascular Disorders | 2 | 2011 | 52 | 0.280 |
Why?
|
| Particulate Matter | 3 | 2022 | 31 | 0.280 |
Why?
|
| Odds Ratio | 3 | 2019 | 472 | 0.270 |
Why?
|
| Dietary Supplements | 2 | 2008 | 185 | 0.270 |
Why?
|
| Gene Frequency | 2 | 2010 | 220 | 0.270 |
Why?
|
| Mortality | 1 | 2007 | 125 | 0.260 |
Why?
|
| Genome-Wide Association Study | 3 | 2022 | 547 | 0.260 |
Why?
|
| United States | 8 | 2022 | 3939 | 0.250 |
Why?
|
| Stroke | 2 | 2015 | 585 | 0.240 |
Why?
|
| Memory | 2 | 2018 | 190 | 0.240 |
Why?
|
| Proxy | 1 | 2004 | 9 | 0.240 |
Why?
|
| Antihypertensive Agents | 5 | 2022 | 352 | 0.230 |
Why?
|
| Hormone Replacement Therapy | 3 | 2022 | 91 | 0.230 |
Why?
|
| Time Factors | 4 | 2020 | 2149 | 0.220 |
Why?
|
| Hypertension | 3 | 2022 | 959 | 0.220 |
Why?
|
| Factor Analysis, Statistical | 2 | 2013 | 77 | 0.210 |
Why?
|
| Vitamin B Complex | 1 | 2022 | 2 | 0.200 |
Why?
|
| Testosterone | 1 | 2022 | 48 | 0.200 |
Why?
|
| Diet, Mediterranean | 1 | 2022 | 31 | 0.200 |
Why?
|
| Air Pollution | 1 | 2021 | 18 | 0.200 |
Why?
|
| Air Pollutants | 1 | 2021 | 24 | 0.200 |
Why?
|
| Risk Assessment | 4 | 2018 | 1426 | 0.200 |
Why?
|
| Health Status | 2 | 2019 | 399 | 0.200 |
Why?
|
| Gait | 1 | 2022 | 142 | 0.190 |
Why?
|
| Mental Disorders | 2 | 2013 | 121 | 0.190 |
Why?
|
| Body Weight | 2 | 2020 | 310 | 0.190 |
Why?
|
| Disease Progression | 3 | 2013 | 594 | 0.190 |
Why?
|
| Age of Onset | 2 | 2018 | 94 | 0.190 |
Why?
|
| Mass Screening | 1 | 2003 | 263 | 0.190 |
Why?
|
| Prospective Studies | 8 | 2022 | 2282 | 0.190 |
Why?
|
| C-Reactive Protein | 2 | 2019 | 238 | 0.190 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2020 | 57 | 0.180 |
Why?
|
| Body Size | 1 | 2020 | 34 | 0.170 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 411 | 0.170 |
Why?
|
| Anthropometry | 1 | 2020 | 83 | 0.170 |
Why?
|
| Apolipoprotein C-I | 1 | 2019 | 4 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2019 | 13 | 0.170 |
Why?
|
| Problem Solving | 1 | 2018 | 28 | 0.160 |
Why?
|
| Gender Identity | 1 | 2018 | 23 | 0.160 |
Why?
|
| Forecasting | 1 | 2019 | 143 | 0.160 |
Why?
|
| Editorial Policies | 1 | 2018 | 15 | 0.160 |
Why?
|
| Blood Pressure | 2 | 2022 | 845 | 0.160 |
Why?
|
| Cost of Illness | 1 | 2018 | 70 | 0.150 |
Why?
|
| Ascorbic Acid | 2 | 2008 | 23 | 0.150 |
Why?
|
| Geriatric Assessment | 2 | 2018 | 390 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 104 | 0.150 |
Why?
|
| Sex Distribution | 2 | 2010 | 191 | 0.150 |
Why?
|
| Diet Surveys | 1 | 2017 | 57 | 0.140 |
Why?
|
| Logistic Models | 1 | 2019 | 781 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2018 | 355 | 0.140 |
Why?
|
| Antioxidants | 2 | 2008 | 115 | 0.140 |
Why?
|
| Anorexia | 1 | 2016 | 5 | 0.140 |
Why?
|
| Continental Population Groups | 1 | 2018 | 237 | 0.140 |
Why?
|
| Decision Making | 1 | 2018 | 195 | 0.140 |
Why?
|
| Age Factors | 4 | 2015 | 1188 | 0.130 |
Why?
|
| Trace Elements | 1 | 2015 | 7 | 0.130 |
Why?
|
| Metals, Heavy | 1 | 2015 | 7 | 0.130 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 42 | 0.130 |
Why?
|
| Ethnic Groups | 1 | 2018 | 476 | 0.130 |
Why?
|
| Translations | 1 | 2014 | 1 | 0.120 |
Why?
|
| Russia | 1 | 2014 | 5 | 0.120 |
Why?
|
| Phenotype | 2 | 2013 | 632 | 0.120 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2014 | 10 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2015 | 122 | 0.120 |
Why?
|
| Language | 1 | 2013 | 42 | 0.110 |
Why?
|
| Executive Function | 1 | 2013 | 57 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 1062 | 0.110 |
Why?
|
| Atrial Fibrillation | 2 | 2015 | 322 | 0.110 |
Why?
|
| Questionnaires | 2 | 2010 | 3 | 0.110 |
Why?
|
| Attention | 1 | 2013 | 83 | 0.110 |
Why?
|
| Registries | 1 | 2014 | 298 | 0.110 |
Why?
|
| Patient Selection | 1 | 2014 | 276 | 0.100 |
Why?
|
| Depression | 3 | 2022 | 444 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2013 | 175 | 0.100 |
Why?
|
| Menopause | 1 | 2012 | 95 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 762 | 0.100 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2012 | 199 | 0.100 |
Why?
|
| Exercise | 3 | 2023 | 672 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 1531 | 0.090 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2011 | 7 | 0.090 |
Why?
|
| Time | 1 | 2010 | 23 | 0.090 |
Why?
|
| Survival Analysis | 3 | 2010 | 483 | 0.090 |
Why?
|
| Environmental Exposure | 2 | 2021 | 91 | 0.090 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 72 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 13 | 0.090 |
Why?
|
| Adult | 5 | 2023 | 9345 | 0.090 |
Why?
|
| Genetic Testing | 1 | 2010 | 96 | 0.090 |
Why?
|
| Sex Factors | 2 | 2015 | 663 | 0.090 |
Why?
|
| Genetics | 1 | 2009 | 4 | 0.090 |
Why?
|
| Toxicology | 1 | 2009 | 6 | 0.090 |
Why?
|
| Neurotoxins | 1 | 2009 | 16 | 0.090 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2009 | 19 | 0.080 |
Why?
|
| Behavior | 1 | 2009 | 30 | 0.080 |
Why?
|
| Actins | 1 | 2009 | 51 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2009 | 63 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2008 | 61 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2010 | 244 | 0.080 |
Why?
|
| Age Distribution | 2 | 2007 | 206 | 0.080 |
Why?
|
| Mental Processes | 1 | 2008 | 17 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2016 | 898 | 0.080 |
Why?
|
| Confidence Intervals | 2 | 2005 | 149 | 0.080 |
Why?
|
| Carotenoids | 1 | 2007 | 10 | 0.070 |
Why?
|
| Neuroprotective Agents | 1 | 2007 | 28 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 145 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2013 | 97 | 0.070 |
Why?
|
| Causality | 1 | 2006 | 38 | 0.070 |
Why?
|
| Religion | 1 | 2006 | 32 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2006 | 108 | 0.070 |
Why?
|
| Genetics, Population | 1 | 2005 | 32 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 257 | 0.060 |
Why?
|
| ROC Curve | 1 | 2003 | 164 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 881 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2023 | 19 | 0.050 |
Why?
|
| Autopsy | 2 | 2015 | 35 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2023 | 43 | 0.050 |
Why?
|
| tau Proteins | 1 | 2023 | 41 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2023 | 45 | 0.050 |
Why?
|
| Histamine H2 Antagonists | 1 | 2002 | 3 | 0.050 |
Why?
|
| Anxiety | 2 | 2016 | 191 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 684 | 0.050 |
Why?
|
| Life Change Events | 1 | 2022 | 21 | 0.050 |
Why?
|
| Acceleration | 1 | 2022 | 65 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 8 | 0.050 |
Why?
|
| Proteomics | 1 | 2023 | 94 | 0.050 |
Why?
|
| Rest | 1 | 2022 | 53 | 0.050 |
Why?
|
| Folic Acid | 1 | 2022 | 12 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 582 | 0.050 |
Why?
|
| Loneliness | 1 | 2022 | 9 | 0.050 |
Why?
|
| Frail Elderly | 1 | 2022 | 68 | 0.050 |
Why?
|
| Dioxygenases | 1 | 2021 | 1 | 0.050 |
Why?
|
| Cause of Death | 2 | 2018 | 236 | 0.050 |
Why?
|
| Public Health | 1 | 2022 | 81 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 112 | 0.050 |
Why?
|
| Estradiol | 1 | 2022 | 136 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2021 | 50 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 876 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 147 | 0.050 |
Why?
|
| Renin-Angiotensin System | 1 | 2022 | 179 | 0.050 |
Why?
|
| Cytokines | 1 | 2022 | 256 | 0.050 |
Why?
|
| Vitamin D | 1 | 2022 | 184 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2022 | 221 | 0.050 |
Why?
|
| Calcium | 1 | 2022 | 307 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2020 | 3306 | 0.040 |
Why?
|
| Algorithms | 1 | 2003 | 495 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2020 | 48 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2020 | 125 | 0.040 |
Why?
|
| Thinness | 1 | 2020 | 33 | 0.040 |
Why?
|
| Quality of Life | 1 | 2006 | 946 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2020 | 90 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 203 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 93 | 0.040 |
Why?
|
| Adiposity | 1 | 2020 | 198 | 0.040 |
Why?
|
| Weight Gain | 1 | 2020 | 117 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2018 | 7 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 218 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2018 | 13 | 0.040 |
Why?
|
| Voluntary Health Agencies | 1 | 2018 | 2 | 0.040 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2018 | 8 | 0.040 |
Why?
|
| China | 1 | 2018 | 50 | 0.040 |
Why?
|
| Asian Americans | 1 | 2018 | 97 | 0.040 |
Why?
|
| Adiponectin | 1 | 2018 | 106 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2018 | 103 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2018 | 177 | 0.040 |
Why?
|
| Contraceptive Agents, Female | 1 | 2017 | 16 | 0.040 |
Why?
|
| Caloric Restriction | 1 | 2018 | 106 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 173 | 0.040 |
Why?
|
| Triglycerides | 1 | 2018 | 230 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 210 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2018 | 247 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2018 | 91 | 0.040 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2017 | 102 | 0.040 |
Why?
|
| Guilt | 1 | 2016 | 1 | 0.030 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2017 | 140 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 313 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2020 | 923 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2018 | 156 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2015 | 187 | 0.030 |
Why?
|
| Survival Rate | 2 | 2007 | 877 | 0.030 |
Why?
|
| Comorbidity | 2 | 2007 | 566 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 1497 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2018 | 1166 | 0.030 |
Why?
|
| Animals | 2 | 2018 | 7541 | 0.030 |
Why?
|
| Irritable Mood | 1 | 2012 | 5 | 0.030 |
Why?
|
| Hispanic Americans | 1 | 2018 | 940 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2012 | 178 | 0.020 |
Why?
|
| Community Health Planning | 1 | 2011 | 9 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 27 | 0.020 |
Why?
|
| African Americans | 1 | 2018 | 1425 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 35 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2010 | 66 | 0.020 |
Why?
|
| Phylogeny | 1 | 2009 | 56 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 2007 | 22 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 293 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2006 | 3509 | 0.020 |
Why?
|
| Food Habits | 1 | 2007 | 1 | 0.020 |
Why?
|
| Linear Models | 1 | 2008 | 447 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 288 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2007 | 35 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2007 | 103 | 0.020 |
Why?
|
| Educational Status | 1 | 2007 | 179 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2007 | 240 | 0.020 |
Why?
|
| Hearing | 1 | 2006 | 11 | 0.020 |
Why?
|
| Vision, Ocular | 1 | 2006 | 33 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 1022 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 475 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 2636 | 0.010 |
Why?
|
| Aspirin | 1 | 2002 | 63 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 297 | 0.010 |
Why?
|